BAUDAX BIO INC (BXRX)
US07160F4046 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -34.43M | -58.80M | -19.77M | -76.10M | -32.56M | |||
| Depreciation Amortization | 2.14M | 2.17M | 2.82M | 2.56M | 480.00K | |||
| Change In Working Capital | 270.00K | 60.00K | -3.08M | 630.00K | -8.88M | |||
| Other non cash items | 16.24M | 28.78M | -29.24M | 28.86M | -9.09M | |||
| OPERATING CASH FLOW | -15.78M | -27.79M | -49.27M | -44.06M | -50.04M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -20.00K | -200.00K | -640.00K | -1.48M | |||
| Other Investing Activity | N/A | 0.00 | 10.00K | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -20.00K | -190.00K | -640.00K | -1.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -5.46M | -2.24M | 0.00 | 10.04M | N/A | |||
| Stock Issued/Repurchased | 17.96M | 19.07M | 12.16M | 29.37M | N/A | |||
| Other Financing Activity | -660.00K | 350.00K | 22.86M | 17.89M | 69.27M | |||
| FINANCING CASH FLOW | 11.85M | 17.18M | 35.01M | 57.30M | 69.27M | |||
| CHANGE IN CASH | -3.79M | -10.63M | -14.45M | 12.60M | 17.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -15.78M | -27.79M | -49.27M | -44.06M | -50.04M | |||
| Capital Expenditure | N/A | -20.00K | -200.00K | -640.00K | -1.48M | |||
| FREE CASH FLOW | -15.80M | -27.81M | -49.47M | -44.70M | -51.52M | |||
All data in USD